End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.74 CNY | +0.15% | -3.80% | -14.77% |
04-26 | Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-19 | Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat | MT |
Sales 2024 * | 20.16B 2.78B 223B | Sales 2025 * | 24.08B 3.32B 266B | Capitalization | 11.77B 1.62B 130B |
---|---|---|---|---|---|
Net income 2024 * | 944M 130M 10.43B | Net income 2025 * | 1.34B 185M 14.8B | EV / Sales 2024 * | 0.44 x |
Net cash position 2024 * | 2.89B 399M 31.98B | Net cash position 2025 * | 2.94B 405M 32.45B | EV / Sales 2025 * | 0.37 x |
P/E ratio 2024 * |
10.5
x | P/E ratio 2025 * |
8.69
x | Employees | 33,176 |
Yield 2024 * |
1.87% | Yield 2025 * |
2.26% | Free-Float | 52.27% |
1 day | +0.15% | ||
1 week | -3.80% | ||
Current month | +3.46% | ||
1 month | +4.11% | ||
3 months | +0.92% | ||
6 months | -11.84% | ||
Current year | -14.77% |
Managers | Title | Age | Since |
---|---|---|---|
Hong Xian Ruan
FOU | Founder | 58 | 07/11/00 |
Dong Lei Xiao
DFI | Director of Finance/CFO | 42 | 31/12/04 |
Guo Wei Ruan
BRD | Director/Board Member | 47 | 29/02/00 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Xian Ruan
FOU | Founder | 58 | 07/11/00 |
Qiong Liu
BRD | Director/Board Member | 59 | 31/05/09 |
Chun Li Guo
BRD | Director/Board Member | 42 | 31/03/03 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 19.74 | +0.15% | 5,814,910 |
25/04/24 | 19.71 | -0.71% | 5,156,000 |
24/04/24 | 19.85 | -0.90% | 6,151,948 |
23/04/24 | 20.03 | -0.84% | 4,231,451 |
22/04/24 | 20.2 | -1.56% | 4,876,308 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.77% | 1.62B | |
-32.21% | 15.27B | |
-31.97% | 10.84B | |
-30.42% | 6.06B | |
+8.14% | 6.04B | |
-11.41% | 5.86B | |
-0.88% | 4.71B | |
+52.19% | 4.29B | |
-12.31% | 3.61B | |
-14.86% | 3.33B |
- Stock Market
- Equities
- 002727 Stock